✦ LIBER ✦

Steatosis is the predictor of relapse in HCV genotype 3- but not 2-infected patients treated with 12 weeks of pegylated interferon-α-2a plus ribavirin and RVR

✍ Scribed by L. Restivo; R. Zampino; B. Guerrera; L. Ruggiero; L. E. Adinolfi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

236 TWELVE-WEEK COURSE OF PIFN-α-2A/RIBA

✍ L.E. Adinolfi; R. Zampino; B. Guerrera; L. Restivo; L. Rinaldi; A. Ciervo; V.R. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 64 KB

817 RANDOMISED CONTROLLED TRIAL OF 24 AN

✍ Foster, G.; Shoeb, D.; Weatherall, A.; Moreea, S.; Vilar, J.; Freshwater, D.; Ry 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Emergence of occult minority genotype 2b

✍ A.J. Buckton; R. Kulasegaram; S.L. Ngui; M. Fisher; R. James; S. Rangarajan; C.G 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 362 KB

[10] THE SAFETY AND EFFICACY OF TARIBAVI

✍ P. Marcellin; Y. Lurie; M. Rodrigues-Torres; R. Chasen; Y. Xu; B. Murphy 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 117 KB

612 WEEK 8 HCV-RNA IS THE OPTIMAL PREDIC

✍ T.-M. Scherzer; H. Kerschner; S. Beinhardt; K. Rutter; H. Hofer; P. Steindl-Mund 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB

M1811 Week 8 HCV-RNA Is the Optimal Pred

✍ Ferenci, Peter; Scherzer, Thomas-Matthias; Kerschner, Heidrun; Beinhardt, Sandra 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 135 KB